| Computational pan-genomics: status, promises and challenges Briefings in bioinformatics 19 (1), 118-135, 2018 | 330 | 2018 |
| A high-quality human reference panel reveals the complexity and distribution of genomic structural variants JY Hehir-Kwa, T Marschall, WP Kloosterman, LC Francioli, JA Baaijens, ... Nature communications 7 (1), 1-10, 2016 | 104 | 2016 |
| Inference of the Russian drug community from one of the largest social networks in the Russian Federation LJ Dijkstra, AV Yakushev, PAC Duijn, AV Boukhanovsky, PMA Sloot Quality & Quantity 48, 2739-2755, 2014 | 20 | 2014 |
| Varlociraptor: enhancing sensitivity and controlling false discovery rate in somatic indel discovery J Köster, LJ Dijkstra, T Marschall, A Schönhuth Genome biology 21, 1-25, 2020 | 19 | 2020 |
| Adverse drug reaction or innocent bystander? A systematic comparison of statistical discovery methods for spontaneous reporting systems L Dijkstra, M Garling, R Foraita, I Pigeot Pharmacoepidemiology and drug safety 29 (4), 396-403, 2020 | 18 | 2020 |
| A heuristic optimization method for mitigating the impact of a virus attack VV Kashirin, LJ Dijkstra Procedia Computer Science 18, 2619-2628, 2013 | 9 | 2013 |
| Enhancing sensitivity and controlling false discovery rate in somatic indel discovery J Köster, LJ Dijkstra, T Marschall, A Schönhuth bioRxiv, 741256, 2019 | 5 | 2019 |
| A high-quality reference panel reveals the complexity and distribution of structural genome changes in a human population JY Hehir-Kwa, T Marschall, WP Kloosterman, LC Francioli, JA Baaijens, ... Biorxiv, 036897, 2016 | 4 | 2016 |
| Variable selection in linear regression models: Choosing the best subset is not always the best choice M Hanke, L Dijkstra, R Foraita, V Didelez Biometrical Journal 66 (1), 2200209, 2024 | 2 | 2024 |
| A discovery and verification approach for pharmacovigilance using electronic health care data LJ Dijkstra, T Schink, R Linder, M Schwaninger, I Pigeot, MN Wright, ... medRxiv, 2022.05. 10.22274885, 2022 | 2 | 2022 |
| Aufdeckung von Arzneimittelrisiken nach der Zulassung: Methodenentwicklung zur Nutzung von Routinedaten der gesetzlichen Krankenversicherungen R Foraita, L Dijkstra, F Falkenberg, M Garling, R Linder, R Pflock, ... Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 61 (9), 1075-1081, 2018 | 2 | 2018 |
| Detection of drug risks after approval: Methods development for the use of routine statutory health insurance data R Foraita, L Dijkstra, F Falkenberg, M Garling, R Linder, R Pflock, ... Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 61, 1075-1081, 2018 | 1 | 2018 |
| From MDMA to Lady Gaga: Expertise and contribution behavior of editing communities on Wikipedia LJ Dijkstra, LJ Krieg Procedia Computer Science 101, 96-106, 2016 | 1 | 2016 |
| An Exposure Model Framework for Signal Detection based on Electronic Healthcare Data L Dijkstra, T Schink, R Foraita arXiv preprint arXiv:2404.14213, 2024 | | 2024 |
| When Choosing the Best Subset Is Not the Best Choice M Hanke, L Dijkstra, R Foraita, V Didelez | | 2021 |
| Detecting adverse drug events in spontaneous reporting data: A systematic comparison L Dijkstra, M Garling, R Foraita, I Pigeot PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 27, 258-258, 2018 | | 2018 |
| Enhancing sensitivity and controlling false discovery rate in somatic indel discovery using a latent variable model LJ Dijkstra, J Köster, T Marschall, A Schönhuth bioRxiv, 121954, 2017 | | 2017 |
| calibro/chemical-wiki: First alpha release M Azzi, L Krieg, G Colombo, M Berning, G Uboldi, L Dijkstra, ... | | 2017 |
| Calibro/chemical-wiki: First alpha release: Chemical Knowledge M Azzi, L Krieg, G Colombo, M Berning, G Uboldi, L Dijkstra, ... Zenodo, 2017 | | 2017 |
| Genotyping somatic insertions and deletions LJ Dijkstra, J Köster, T Marschall, A Schönhuth | | 2016 |
